Synapse - Pediatrics, Department of

Results (5319)

Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802)

Meeting Abstract

Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program

Meeting Abstract

Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Distribution and clinical significance of FGFR alterations in pediatric and AYA gliomas

Meeting Abstract

Nobre, L.; Farouk, S.; Larsen, A.; Bennett, J.; Ho, I. C.; Siddaway, R.; Mellinghoff, I.; Perreault, S.; Magimairajan, V.; Larouche, V.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)

Meeting Abstract

Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

"Tazni": A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors (NCT05407441)

Meeting Abstract

Yi, J. S.; Czaplinski, J.; Bhushan, K.; Forrest, S. J.; Shukla, N.; Mack, S.; Hong, A.; Strachan, M.; Dubois, S. G.; London, W. B.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Pediatric Brain Tumor Consortium (PBTC)-056: A phase 1 study of the ADAM-10 Inhibitor, INCB007839, in children with recurrent/progressive high-grade gliomas to target microenvironmental neurologin-3

Meeting Abstract

Lenzen, A.; Partap, S.; Billups, C.; Poussaint, T. Y.; Sait, S. F.; Robison, N.; Castellino, C. C.; Felker, J.; Stewart, C.; Fangusaro, J.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

The landscape of gliomas in children, adolescents and young adults reveals insights on gliomagenesis: A Canadian Adolescents and Young Adults Neuro-Oncology Network (CANON) study

Meeting Abstract

Bennett, J.; Levine, A.; Nobre, L.; Negm, L.; Chung, J.; Fang, K.; Johnson, M.; Komosa, M.; Krumholtz, S.; Nunes, N. M.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Interception treatment strategy for incidental lesions in children, adolescents and young adults (AYA) using laser interstitial thermal therapy (LITT)

Meeting Abstract

Nguyen, R. H.; Guadix, S.; Donzelli, M.; Sanders, C.; Rosenblum, M. K.; Bale, T. A.; Greenfield, J. P.; Souweidane, M. M.
Neuro-Oncology (2024)

Fulltext@MSK | Save

Phase II study of axitinib in patients with neurofibromatosis type 2-related schwannomatosis and progressive vestibular schwannomas

Meeting Abstract

Garcia, M. R.; Hagiwara, M.; Yaffe, A.; Mitchell, C.; Akshintala, S.; Nicolaides, T.; Phadnis, S. S.; Yohay, K.; Feng, Y.; Goldberg, J. D.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Establishing the time-dependence of CDK4/6 inhibitor efficacy in pediatric brain tumors and feasibility of metronomic intrathecal delivery in a preclinical model

Meeting Abstract

Martin, B.; Guadix, S.; Sathian, R.; Laramee, M.; Pandey, A.; Ray, I.; Chen-Kiang, S.; Wang, A.; Davuluri, R.; Dahmane, N.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save